Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Carmine N. Stengone, Chief Executive Officer and President of Contineum Therapeutics, Inc. (NASDAQ: CTNM), has executed a series of stock transactions involving both sales and acquisitions. These activities, conducted under a pre-arranged 10b5-1 trading plan, include the sale of 10,000 shares at a weighted average price of $16.008 and the acquisiti…
MediaAlpha CEO Steven Yi sold 96,000 shares worth approximately $1.24 million on July 1, 2026, under a Rule 10b5-1 plan primarily to cover tax obligations from restricted stock unit vesting. The sale coincides with a 19% weekly stock surge, strong Q1 2026 revenue exceeding forecasts, and the appointment of new board member Lauren StClair.
Steven S. Fendley, President of the US Division at Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), completed a stock sale on June 29, 2026, under a pre-arranged 10b5-1 trading plan. The transaction involved the disposal of 7,000 shares, generating proceeds of $338,556. This disclosure, filed with the Securities and Exchange Commission on …
McBee Brannin, CoreWeave's Chief Development Officer, has executed a series of transactions resulting in the sale of 55,400 Class A Common Stock shares, valued at approximately $5.23 million. The sales, conducted through various trusts including the Canis Major 2024 Irrevocable Trust LLC and several Grantor Retained Annuity Trusts, were facilitated…
CoreWeave, Inc. (CRWV) Chief Development Officer Brannin McBee sold 194,000 shares of Class A Common Stock on June 29, 2026, realizing approximately $18.3 million. The transaction, facilitated by a Rule 10b5-1 trading plan established in March 2026, occurred at prices between $90.24 and $98.31 per share. This activity follows a recent 15% decline i…
Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 4,641 shares on July 1, 2026, generating $20,838 in proceeds. The transaction, intended to satisfy tax liabilities from performance-based Restricted Stock Units, occurred at an average price of $4.49 per share. This activity follows the compan…
C3.ai Inc. (NASDAQ: AI) reported that Chief Financial Officer Hitesh Lath sold $426,388 worth of Class A Common Stock on June 30, 2026, according to a recent SEC filing. The transaction involved 48,619 shares at a weighted-average price of $8.77, with the stock currently trading at $9.43. While the company issued preliminary fiscal 2027 revenue gui…
Sunrun Inc. director Lynn Michelle Jurich recently liquidated a portion of her equity stake, selling 50,000 shares for $680,320. The transaction, executed on July 1, 2026, follows a Rule 10b5-1 trading plan adopted in June 2025. This insider activity unfolds against a backdrop of recent financial outperformance and shifting analyst projections for …
Richard Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 25,947 shares of common stock on July 1, 2026, totaling $116,242. The transaction, conducted at prices ranging from $4.3402 to $4.7507 with a weighted average of $4.48 per share, was specifically designated to satisfy tax liabilities arisin…
Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker Inc., executed a sale of 36,300 shares of Class A Common Stock on June 29, 2026, resulting in proceeds totaling approximately $1,090,452. The transaction, governed by a Rule 10b5-1 trading plan adopted on September 16, 2025, occurred at per-share prices between $29.99 and $30.35. Th…
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Chief Medical Officer Narinder Pal Bhalla executed a sale of 22,306 shares on July 1, 2026, totaling $98,592. The transaction, conducted at a weighted average price of $4.42 per share, was specifically designated to satisfy tax liabilities associated with the vesting of performance Restricted Stock Units (RSUs…
Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a transaction involving the sale of 4,666 shares of common stock on July 1, 2026. The sale, valued at $20,903, was conducted to satisfy tax liabilities associated with the vesting of performance Restricted Stock Units (RSUs). This transaction follows a pr…
Josh D. Paul, the Chief Accounting Officer at Palo Alto Networks Inc (NASDAQ:PANW), has reduced his stake in the cybersecurity firm through recent share transactions. While one portion of the sale was executed under a Rule 10b5-1 plan, another involved shares withheld for tax obligations related to vesting restricted stock units. The executive's ac…
StoneX Group Inc. CEO Philip Andrew Smith executed a significant divestment of company equity, selling 51,540 shares for approximately $6.12 million on June 30, 2026. The transactions followed the exercise of stock options originally granted in December 2021. This financial activity occurs against a backdrop of mixed financial results for the secon…
ClearPoint Neuro Inc. (NASDAQ: CLPT) Chief Executive Officer Joseph Burnett has completed the sale of 20,000 shares of the company's common stock. The transaction, executed on June 29, 2026, was conducted under a pre-arranged trading plan established in June 2025. The sale followed the exercise of stock options originally granted in November 2017. …
Michael Olsen, General Counsel and Chief Compliance and Risk Officer at Optimum Communications, Inc., recently finalized several share transactions, including a direct sale and tax-related withholdings. These moves occur against a backdrop of significant corporate restructuring efforts, including a completed tender offer and a credit rating downgra…
Andrew Toy, Chief Executive Officer of Clover Health Investments, Corp., executed a mandatory stock sale on July 1, 2026, to satisfy tax withholding requirements tied to restricted stock unit vesting. The transaction occurred amid recent financial results that showed revenue growth but earnings per share below analyst expectations, alongside a sign…
Precigen Inc. CFO Harry Thomasian Jr. sold 200,000 shares worth approximately $1.1 million between June 29 and July 1, 2026, under a 10b5-1 plan. The sales occurred after a 262% stock surge over the past year, with shares currently trading around $5.25. Despite the executive's divestment, the company reported Q1 2026 earnings that beat analyst expe…
Sushil Patel, a director at Revolution Medicines, Inc. (NASDAQ:RVMD), completed a series of stock transactions on June 29, 2026, resulting in the sale of 5,580 shares for approximately $1.05 million. The activity, conducted under a pre-arranged 10b5-1 trading plan established in March 2026, included the exercise of fully vested stock options at $37…
Rutul R. Shah, Chief Operating Officer at Precigen, Inc. (NASDAQ:PGEN), disposed of shares valued at $251,105 on June 29, 2026, following the exercise of fully vested stock options. The transaction was conducted under a 10b5-1 plan, leaving Shah with a direct holding of 497,751 shares and 157,076 derivative options. This activity occurs against a b…
John Kent Walker, President of Global Affairs and Chief Legal Officer at Alphabet Inc. (NASDAQ:GOOGL), executed a sale of Class C Capital Stock valued at approximately $3.14 million on June 29, 2026. The transaction was facilitated through a Rule 10b5-1 trading plan established by Walker in his capacity as a trustee for The Arete Trust. This divest…
Precigen Inc. (NASDAQ: PGEN) President and CEO Helen Sabzevari completed the sale of 346,836 shares of company stock on June 29, 2026, generating proceeds of $2,042,864. The transaction followed the exercise of equivalent stock options and occurred near the stock's 52-week high, reflecting a period of significant valuation appreciation. This execut…
Airbnb, Inc. (NASDAQ: ABNB) director and 10% owner Joseph Gebbia sold 294,903 shares of Class A Common Stock on June 29, 2026, realizing approximately $43.8 million from the transaction. The shares were sold at prices ranging from $145.90 to $150.0326 per share. The sale was executed indirectly through the Sycamore Trust under a Rule 10b5-1 trading…
Anthony Bacos, Stitch Fix’s Chief Product and Technology Officer, sold $309,663 worth of the company’s Class A Common Stock on June 29, 2026, under a Rule 10b5-1 trading plan established earlier in the year. The sale of 70,011 shares occurred at prices between $4.35 and $4.51, shortly after the company reported stronger-than-expected fiscal third-q…
Fernando Austin Pena, President and Director at Blackstone Mortgage Trust, Inc. (NASDAQ:BXMT), executed a sale of 1,670 shares of Class A Common Stock on June 30, 2026. The transaction, valued at $28,509, was conducted under Rule 10b5-1 trading plans established to meet tax withholding obligations. This sale takes place as BXMT trades near its 52-w…
